SCHEMBL25341847

SCHEMBL25341847

COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCN(CCOCCC(=O)OC(C)(C)C)CC1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 19/20 0.72
▸ ERBB2 P04626 3/20 0.69
▸ KDR P35968 2/20 0.69
▸ BRAF P15056 2/20 0.69
▸ CIT O14578 1/20 0.69
▸ GAK O14976 1/20 0.69
▸ EPHB6 O15197 1/20 0.69
▸ ABCC4 O15439 1/20 0.69
▸ DAPK3 O43293 1/20 0.69
▸ RIPK2 O43353 1/20 0.69
▸ NR1I2 O75469 1/20 0.69
▸ RPS6KA4 O75676 1/20 0.69
▸ STK17B O94768 1/20 0.69
▸ STK10 O94804 1/20 0.69
▸ PRKD3 O94806 1/20 0.69
▸ ABCB11 O95342 1/20 0.69
▸ MAP4K4 O95819 1/20 0.69
▸ CHEK2 O96017 1/20 0.69
▸ ABL1 P00519 1/20 0.69
▸ LCK P06239 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31502861 1.00 EGFR (0.72) EGFRERBB2KDRBRAFCIT
SCHEMBL30879224 0.89 EGFR (0.75) EGFRERBB2KDRBRAFCIT
SCHEMBL4220279 0.89 EGFR (0.75) EGFRERBB2KDRBRAFCIT
SCHEMBL30213428 0.89 EGFR (0.75) EGFRERBB2KDRBRAFCIT
SCHEMBL4226041 0.87 EGFR (0.81) EGFRERBB2KDRBRAFCIT
SCHEMBL25599836 0.86 EGFR (0.76) EGFRERBB2KDRBRAFCIT
SCHEMBL24637154 0.85 EGFR (0.83) EGFRERBB2KDRBRAFCIT
SCHEMBL17557967 0.85 EGFR (0.75) EGFRERBB2KDRBRAFCIT
SCHEMBL22338480 0.85 EGFR (0.92) EGFRERBB2KDRBRAFCIT
SCHEMBL25599785 0.85 EGFR (0.77) EGFRERBB2KDRBRAFCIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023143589-A1 CEREBLON E3 UBIQUITIN LIGASE INHIBITOR 甘李药业股份有限公司 2023-08-03 — — WO disclosed
Send feedback